(-)-Epiafzelechin
CAS No. 24808-04-6
(-)-Epiafzelechin ( —— )
产品货号. M30905 CAS No. 24808-04-6
(-)-Epiafzelechin exhibits significant anti-inflammatory activity on carrageenin-induced mouse paw edema, it exhibits a dose-dependent inhibition on the COX activity with an IC50 value of 15 microM, it exhibits about 3-fold weaker inhibitory potency on the enzyme activity than indomethacin as a positive control.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥1786 | 有现货 |
|
| 10MG | ¥2679 | 有现货 |
|
| 25MG | ¥4343 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称(-)-Epiafzelechin
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述(-)-Epiafzelechin exhibits significant anti-inflammatory activity on carrageenin-induced mouse paw edema, it exhibits a dose-dependent inhibition on the COX activity with an IC50 value of 15 microM, it exhibits about 3-fold weaker inhibitory potency on the enzyme activity than indomethacin as a positive control.
-
产品描述(-)-Epiafzelechin exhibits significant anti-inflammatory activity on carrageenin-induced mouse paw edema, it exhibits a dose-dependent inhibition on the COX activity with an IC50 value of 15 microM, it exhibits about 3-fold weaker inhibitory potency on the enzyme activity than indomethacin as a positive control.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number24808-04-6
-
分子量274.3
-
分子式C15H14O5
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 50 mg/mL (182.30 mM)
-
SMILES——
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
trans,trans-2,4-Deca...
trans,trans-2,4-Dedecienal 是亚油酸的脂质过氧化产物
-
[D-Pro2,D-Trp6,8,Nle...
(D-Pro2,D-Trp6,8,Nle10)-Neurokinin B 是 Neurokinin B (Neurokinin Receptor) 的竞争性拮抗剂,pA2 为 5.5,对 Substance P 或 Neurokinin A 没有影响。
-
OVA Peptide (257-264...
OVA Peptide (257-264) TFA is a class I (Kb)-restricted peptide epitope of OVA, an octameric peptide from ovalbumin presented by the class I MHC molecule, H-2Kb.
021-51111890
购物车()
sales@molnova.cn

